Meet Ultima Genomics at the Canadian Conference on Circulating Biomarkers
Our team is enthusiastic to join the CCCB meeting this year, to discuss how our whole-genome sequencing method, ppmSeq™ for minimal residual disease (MRD) detection, is redefining what’s possible in cancer genomics. From accelerating large‑scale studies to enabling earlier, more precise detection of recurrence, Ultima is delivering the power, speed, and resolution researchers need to unlock the next breakthroughs in cancer science.
Poster presentation
Lunch and poster session • Saturday, June 6 • 12:30 - 2:00 PM
Decentralized and cost-effective ultrasensitive MRD testing via ppmSeq TM
Presenter: Geoff Lowman, PhD
See the posterMeet with us at CCCB 2026
Contact us to request an in person meeting at CCCB with Alissa Nolan, Sales Director, Genomics Applications, Northeast, and Geoff Lowman, Senior Staff NGS Applications Manager.
Book a meeting